MoneyWorks4Me

Astrazeneca Pharma I - Quaterly Results

14 Aug 2025 Evaluate
The Sales for the quarter ended June 2025 of Rs. 5263.10 millions rose by 35.81% from Rs. 3875.20 millions.The Total Profit for the quarter ended June 2025 of Rs. 558.30 millions grew from Rs.-117.90 millionsOP of the company witnessed a marginal growth to 923.50 millions from 464.20 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 5263.10 3875.20 35.81 5263.10 3875.20 35.81 17162.90 12955.30 32.48
Other Income 112.40 83.50 34.61 112.40 83.50 34.61 406.30 348.00 16.75
PBIDT 923.50 464.20 98.94 923.50 464.20 98.94 2946.00 2192.50 34.37
Interest 7.20 1.10 554.55 7.20 1.10 554.55 14.60 12.00 21.67
PBDT 912.70 -112.50 -911.29 912.70 -112.50 -911.29 1963.50 2344.80 -16.26
Depreciation 165.70 39.10 323.79 165.70 39.10 323.79 399.90 149.40 167.67
PBT 747.00 -151.60 -592.74 747.00 -151.60 -592.74 1563.60 2195.40 -28.78
TAX 188.70 -33.70 -659.94 188.70 -33.70 -659.94 406.20 580.30 -30.00
Deferred Tax -32.30 -141.20 -77.12 -32.30 -141.20 -77.12 -199.20 -9.00 2113.33
PAT 558.30 -117.90 -573.54 558.30 -117.90 -573.54 1157.40 1615.10 -28.34
Equity 50.00 50.00 0.00 50.00 50.00 0.00 50.00 50.00 0.00
PBIDTM(%) 17.55 11.98 46.48 17.55 11.98 46.48 17.16 16.92 1.43
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..